top of page
Admin 1
Admin
More actions
Profile
Join date: Oct 18, 2025
Posts (9)
Sep 23, 2025 ∙ 3 min
Why Pharma Growth in Southeast Asia Will Continue to Outpace Global Markets in the Next Decade?
Global pharma markets are stagnating. Europe is constrained by price caps with flat growth, the US by reimbursement politics, and Latin...
4
0
Sep 20, 2025 ∙ 4 min
Winning in Vietnam means mastering execution, not chasing forecasts.
Vietnam offers EU pharma firms a rare structural advantage: EU-GMP quality is rewarded with higher-tier pricing and EVFTA tariff relief. But success is rarely about dossiers alone. Hospitals impose strict shelf-life and labeling rules, tenders fragment across regions, and distributors often overpromise volumes they cannot deliver. Winning in Vietnam means mastering execution, not chasing forecasts.
2
0
Sep 20, 2025 ∙ 4 min
Cambodia, Laos, Myanmar: The Frontier Question
Cambodia, Laos, and Myanmar often tempt EU pharma companies as easy add-ons to ASEAN expansion. Together, they represent ~85 million people, but low spend, fragmented distribution, and volatile regulation make them high-friction markets. Success depends on niche portfolios, strong distributors, and treating them as extensions of regional hubs—not standalones. For the prepared, they add optional upside; for the unprepared, they drain resources.
1
0
bottom of page